Security
Exicure, Inc. Common Stock · XCUR
XCURNASDAQCommon stockCurrentCIK 1698530Updated Nov 21, 2026
XCUR price & chart
Loading TradingView…
NASDAQ:XCUR on TradingView ↗About the company
Exicure, Inc. (Nasdaq: XCUR) is a biotechnology company focused on advancing innovative healthcare technologies and pursuing strategic growth opportunities. The Company’s portfolio includes a clinical-stage program targeting stem cell mobilization for multiple myeloma, sickle cell disease, and cell and gene therapy applications. Exicure is expanding its strategic focus to include medical device technologies designed to address unmet needs in Parkinson’s disease and other healthcare markets.
In the news
No coverage from other publishers is available.
Recent filings
10-Q filing
Regulation FD Disclosure
Items 7.01, 9.01
NT 10-Q filing
DEF 14A filing
Entry into a Material Definitive Agreement · Regulation FD Disclosure
Items 1.01, 7.01, 9.01
Show 5 more recent filings
PRE 14A filing
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Items 3.01
10-Q filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Regulation FD Disclosure
Items 7.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 15,267,000Source | 10,631,000Source | 11,397,000Source | 18,738,000Source | 10,688,000Source | 12,755,000Source | 20,680,000Source | 10,711,000Source | 14,041,000Source | 15,056,000Source | 11,580,000Source | 23,328,000Source |
| Property, Plant and Equipment, NetUSD | 527,000Source | 33,000Source | 178,000Source | 712,000Source | 40,000Source | 219,000Source | 565,000Source | 47,000Source | 306,000Source | 26,000Source | 54,000Source | 2,530,000Source |
| GoodwillUSD | 3,340,000Source | — | 4,399,000Source | 3,340,000Source | — | 4,399,000Source | 3,340,000Source | — | 4,399,000Source | — | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 3,784,000Source | — | 3,784,000Source | 3,784,000Source | — | 3,784,000Source | 3,784,000Source | — | 3,784,000Source | — | — | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 4,438,000Source | 343,000Source | — | 7,858,000Source | 528,000Source | — | 10,420,000Source | 366,000Source | — | — | 816,000Source | 8,577,000Source |
| Assets, CurrentUSD | 5,439,000Source | 2,600,000Source | 2,322,000Source | 8,646,000Source | 2,079,000Source | 3,532,000Source | 11,305,000Source | 1,463,000Source | 4,624,000Source | 13,673,000Source | 2,024,000Source | 10,051,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 946,000Source | 907,000Source | 597,000Source | 711,000Source | 992,000Source | 868,000Source | 713,000Source | 1,096,000Source | 820,000Source | 644,000Source | 1,193,000Source | 1,474,000Source |
| Operating Lease, Right-of-Use AssetUSD | 289,000Source | 5,926,000Source | 0Source | 264,000Source | 6,126,000Source | 9,000Source | 237,000Source | 6,323,000Source | — | 0Source | 6,517,000Source | 7,257,000Source |
| Other Assets, NoncurrentUSD | 1,888,000Source | 2,072,000Source | 714,000Source | 1,992,000Source | 2,443,000Source | 821,000Source | 1,449,000Source | 2,878,000Source | 928,000Source | 1,357,000Source | 2,985,000Source | 3,490,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 8,340,000Source | 9,086,000Source | 10,420,000Source | 9,875,000Source | 9,075,000Source | 10,657,000Source | 9,298,000Source | 8,504,000Source | 10,115,000Source | 8,284,000Source | 8,549,000Source | 8,406,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 1,000Source | 0Source | 1,000Source | 1,000Source | 1,000Source | 1,000Source | 1,000Source | 1,000Source | 1,000Source | 1,000Source | 1,000Source | 0Source |
| Additional Paid in CapitalUSD | 208,136,000Source | 193,628,000Source | 208,137,000Source | 207,636,000Source | 192,604,000Source | 208,137,000Source | 207,635,000Source | 192,598,000Source | 208,137,000Source | 206,035,000Source | 192,593,000Source | 187,571,000Source |
| Retained Earnings (Accumulated Deficit)USD | -201,312,000Source | -192,083,000Source | -207,159,000Source | -198,875,000Source | -190,992,000Source | -206,038,000Source | -196,254,000Source | -190,392,000Source | -204,210,000Source | -199,264,000Source | -189,563,000Source | -172,649,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 102,000Source | — | -2,000Source | 101,000Source | — | -2,000Source | — | — | -2,000Source | — | 0Source | 0Source |
| Stockholders' Equity Attributable to ParentUSD | 6,927,000Source | 1,545,000Source | 977,000Source | 8,863,000Source | 1,613,000Source | 2,098,000Source | 11,382,000Source | 2,207,000Source | 3,926,000Source | 6,772,000Source | 3,031,000Source | 14,922,000Source |
| Liabilities and EquityUSD | 15,267,000Source | 10,631,000Source | 11,397,000Source | 18,738,000Source | 10,688,000Source | 12,755,000Source | 20,680,000Source | 10,711,000Source | 14,041,000Source | 15,056,000Source | 11,580,000Source | 23,328,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 2,769,000Source | 3,655,000Source | 4,170,000Source | 4,569,000Source | 3,431,000Source | 4,460,000Source | 3,889,000Source | 2,661,000Source | 3,888,000Source | 3,071,000Source | 2,510,000Source | 1,639,000Source |
| Operating Lease, Liability, CurrentUSD | 340,000Source | 697,000Source | 0Source | 476,000Source | 671,000Source | 22,000Source | 592,000Source | 650,000Source | 176,000Source | 722,000Source | 626,000Source | 539,000Source |
| Accounts Payable, CurrentUSD | 1,307,000Source | 1,337,000Source | 2,185,000Source | 1,838,000Source | 1,585,000Source | 2,445,000Source | 1,210,000Source | 1,825,000Source | 1,690,000Source | 1,031,000Source | 1,631,000Source | 361,000Source |
| Operating Lease, Liability, NoncurrentUSD | 0Source | 5,431,000Source | — | 0Source | 5,644,000Source | — | 27,000Source | 5,843,000Source | 0Source | 5,213,000Source | 6,039,000Source | 6,767,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | — | 423,000Source | — | — | 423,000Source | — | — | 423,000Source | — | — | — |
| Other Liabilities, NoncurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 1,462,000Source | 2,318,000Source | 1,985,000Source | 2,731,000Source | 846,000Source | 2,015,000Source | 2,679,000Source | 836,000Source | 2,198,000Source | 2,040,000Source | 879,000Source | 1,278,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 423,000Source | 0Source | 0Source | 0Source |
| Long-term Debt, Current MaturitiesUSD | — | — | — | — | 1,000,000Source | — | — | — | — | — | — | 0Source |
| Short-term InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | — | 0Source | 2,000Source | 22,000Source | 1,348,000Source | 1,369,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | — | — | -1,342,000Source | 506,000Source | — | 0Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 755,000Source | -427,000Source | 177,000Source | -193,000Source | 1,270,000Source | -3,052,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -636,000Source | — | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -1,142,000Source | -1,598,000Source | -8,555,000Source | -2,910,000Source | -10,357,000Source | -35,658,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 0Source | -2,090,000Source | -1,807,000Source | 0Source | -1,078,000Source | 4,696,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | 1,000Source | — | 0Source | 10,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | — | — | — | 0Source | 123,000Source | 4,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 0Source | 1,600,000Source | 1,600,000Source | 13,402,000Source | 3,674,000Source | -3,105,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 7,500,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -1,142,000Source | -2,088,000Source | -8,762,000Source | 10,492,000Source | -7,761,000Source | -34,067,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 4,438,000Source | 951,000Source | 1,717,000Source | 7,858,000Source | 2,604,000Source | 10,420,000Source | 3,746,000Source | 12,508,000Source | 2,016,000Source | 9,777,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 2,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | 5,000Source | — | — | — | — | — | 22,000Source | 1,348,000Source | 1,369,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 477,000Source |
| Depreciation, Amortization and Accretion, NetUSD | — | — | — | — | — | — | 49,000Source | 61,000Source | 242,000Source | 28,000Source | 634,000Source | 1,163,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | -4,000Source | 0Source | 9,000Source | -60,000Source | -37,000Source | -26,000Source | -90,000Source | 0Source | -920,000Source | — |
| Gain (Loss) on Termination of LeaseUSD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 5,974,000Source | 5,974,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 1,499,000Source | 1,434,000Source | 889,000Source | 1,514,000Source | 1,291,000Source | 2,217,000Source | 6,831,000Source | 5,449,000Source | 12,653,000Source | 10,890,000Source |
| GoodwillUSD | — | — | 3,340,000Source | — | 4,399,000Source | 3,340,000Source | 4,399,000Source | 3,340,000Source | 4,399,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 8,000Source | 0Source | 0Source | 0Source | 0Source | -634,000Source | 8,000Source | 0Source | 209,000Source |
| InterestExpenseNonoperatingUSD | — | — | 0Source | 12,000Source | — | — | — | — | 1,000Source | 18,000Source | — | — |
| Investment Income, InterestUSD | — | — | 29,000Source | 1,000Source | 11,000Source | 4,000Source | 0Source | 5,000Source | 29,000Source | 8,000Source | 32,000Source | 15,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,437,000Source | -1,091,000Source | -1,121,000Source | -2,621,000Source | -1,828,000Source | 3,010,000Source | -4,946,000Source | -9,701,000Source | -16,914,000Source | -2,582,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | -1,828,000Source | 3,010,000Source | -4,946,000Source | -9,701,000Source | -16,914,000Source | -2,582,000Source |
| Nonoperating Income (Expense)USD | — | — | -46,000Source | 1,489,000Source | -67,000Source | -112,000Source | -188,000Source | 87,000Source | -1,347,000Source | 2,539,000Source | -1,918,000Source | -542,000Source |
| Operating ExpensesUSD | — | — | 2,391,000Source | 2,572,000Source | 1,054,000Source | 2,509,000Source | 1,640,000Source | -2,923,000Source | 4,233,000Source | 12,732,000Source | 14,996,000Source | 30,657,000Source |
| Operating Lease, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 5,721,000Source | — | — |
| Other Nonoperating Income (Expense)USD | — | — | -11,000Source | 1,500,000Source | -26,000Source | -9,000Source | — | -26,000Source | -275,000Source | 2,137,000Source | -2,000Source | -40,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 0Source | 1,600,000Source | 1,600,000Source | 12,402,000Source | 5,440,000Source | 5,040,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Gain (Loss) on Disposition of Other Assets | — | — | — | — | — | — | — | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 500,000Source | 0Source | 28,826,000Source |
| Operating Income (Loss)USD | — | — | -2,391,000Source | -2,572,000Source | -1,054,000Source | -2,509,000Source | -1,640,000Source | 2,923,000Source | -4,233,000Source | -12,232,000Source | -14,996,000Source | -1,831,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -11,000Source | 1,500,000Source | -26,000Source | -9,000Source | — | -26,000Source | -275,000Source | 2,137,000Source | -2,000Source | -40,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -2,437,000Source | -1,083,000Source | -1,121,000Source | -2,621,000Source | -1,828,000Source | 3,010,000Source | -5,580,000Source | -9,693,000Source | -16,914,000Source | -2,373,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 8,000Source | 0Source | 0Source | 0Source | 0Source | -634,000Source | 8,000Source | 0Source | 209,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,437,000Source | -1,091,000Source | -1,121,000Source | -2,621,000Source | -1,828,000Source | 3,010,000Source | -4,946,000Source | -9,701,000Source | -16,914,000Source | -2,582,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.39Source | -0.57Source | -0.18Source | -0.41Source | -0.29Source | 0.49Source | -0.79Source | -4.75Source | -2.11Source | -0.56Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.39Source | -0.57Source | -0.18Source | -0.41Source | -0.29Source | 0.49Source | -0.79Source | -4.75Source | -2.11Source | -0.56Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 6,322,078Source | 1,899,412Source | 6,373,928Source | 6,317,744Source | 6,373,903Source | 6,172,268Source | 6,297,094Source | 2,043,278Source | 8,013,840Source | 4,619,471Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 6,322,078Source | 1,899,412Source | 6,373,928Source | 6,317,744Source | 6,373,903Source | 6,182,679Source | 6,297,094Source | 2,043,278Source | 8,013,840Source | 4,619,471Source |
| Interest Expense (non-operating)USD | — | — | 0Source | 12,000Source | — | — | — | — | 1,000Source | 18,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 2,000Source | 8,000Source | 0Source | 209,000Source |
| General and Administrative ExpenseUSD | — | — | 1,499,000Source | 1,434,000Source | 889,000Source | 1,514,000Source | 1,291,000Source | 2,217,000Source | 6,831,000Source | 5,449,000Source | 12,653,000Source | 10,890,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 595,000Source |
| Investment Income, InterestUSD | — | — | 29,000Source | 1,000Source | 11,000Source | 4,000Source | 0Source | 5,000Source | 29,000Source | 8,000Source | 32,000Source | 15,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | -1,828,000Source | 3,010,000Source | -4,946,000Source | -9,701,000Source | -16,914,000Source | -2,582,000Source |
| Nonoperating Income (Expense)USD | — | — | -46,000Source | 1,489,000Source | -67,000Source | -112,000Source | -188,000Source | 87,000Source | -1,347,000Source | 2,539,000Source | -1,918,000Source | -542,000Source |
| Operating ExpensesUSD | — | — | 2,391,000Source | 2,572,000Source | 1,054,000Source | 2,509,000Source | 1,640,000Source | -2,923,000Source | 4,233,000Source | 12,732,000Source | 14,996,000Source | 30,657,000Source |
| Research and Development ExpenseUSD | — | — | 888,000Source | 0Source | 174,000Source | 935,000Source | 312,000Source | 808,000Source | 3,286,000Source | 0Source | 1,423,000Source | 19,767,000Source |
Filing attachments
xcur-ex99_1.htm · 8-K · 2026-11-20
Exhibit 99.1 Exicure Announces Strategic Expansion into Parkinson’s Disease X-CUE Smart Glasses Ready for Clinical Trials Following Over a Decade of Development WILMINGTON, Del., November 20, 2026 - Exicure, Inc. (Nasdaq: XCUR) (“Exicure” or the “Company”) today announced that on November 19, 2026, it entered into a Strategic Business Expansion and Investment Agreement with NeuroQ Biologics Inc. (“NeuroQ”) and Laonz Co., Ltd. (“Laonz”) to expand its business into medical device technologies d…
Read attachment ↗xcur-ex99_1.htm · 8-K · 2026-11-10
Exicure, Inc. Announces Agreement to Sell GPC-100 Program Assets to GPCRT Inc. for KRW 6.5 Billion WILMINGTON, Del., November 10, 2026 - Exicure, Inc. (Nasdaq: XCUR) (“Exicure” or the “Company”) today announced that on November 4, 2026, the Company and its wholly owned subsidiary, GPCR Therapeutics USA Inc. (“GPCR USA”), entered into an Intellectual Property, Asset and License Assignment Agreement (the “Agreement”) with GPCRT Inc. (“GPCRT”), a company organized under the laws of the Republic of…
Read attachment ↗xcur-ex99_1.htm · 8-K · 2026-09-16
EX-99.1 2 xcur-ex99_1.htm EX-99.1 EX-99.1 Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement WILMINGTON, Del., September 16, 2026 - Exicure, Inc. (Nasdaq: XCUR) (“Exicure” or the “Company”) today announced that, on September 10, 2026, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company an extension through December 2, 2026 to regain compliance with Nasdaq Listing Rule 5550(b…
Read attachment ↗